Rainbow Childrens Medicare Limited (IN:RAINBOW)
:RAINBOW
RAINBOW Stock Chart & Stats
₹1348.80
-₹22.20(-1.36%)
At close: 4:00 PM EST
₹1348.80
-₹22.20(-1.36%)
Day’s Range― - ―
52-Week Range₹1,008.75 - ₹1,644.10
Previous CloseN/A
Volume60.55K
Average Volume (3M)8.91K
Market Cap
₹118.16B
Enterprise Value₹126.15B
Total Cash (Recent Filing)₹4.42B
Total Debt (Recent Filing)₹8.16B
Price to Earnings (P/E)46.2
Beta0.40
Next Earnings
May 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.22%
Share Statistics
EPS (TTM)7.10
Shares Outstanding101,559,160
10 Day Avg. Volume4,219
30 Day Avg. Volume8,914
Financial Highlights & Ratios
PEG Ratio4.75
Price to Book (P/B)9.54
Price to Sales (P/S)9.24
P/FCF Ratio56.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.68
Revenue Forecast (FY)₹16.72B
Bulls Say, Bears Say
Bulls Say
Specialized Pediatric & Women's Care NetworkRainbow’s concentrated network delivering tertiary/quaternary pediatric and women’s specialty care creates durable competitive advantages: high clinical barriers to entry, strong referral flows, repeat demand from families, and the ability to capture higher-acuity cases that sustain revenue mix and pricing power over time.
Sustained Revenue GrowthMulti-year revenue expansion of this magnitude reflects persistent demand, capacity additions and successful service penetration. Sustained top-line growth supports operating leverage, funds reinvestment in specialties, and underpins long-term margin improvement if cost control continues.
Strong Operating Cash Flow & Free Cash FlowImproving operating cash conversion and rising free cash flow provide durable financial flexibility: they enable funding of capex for specialized units, reduce reliance on external financing, support deleveraging or strategic expansion, and cushion the business versus cyclical demand swings.
Bears Say
Rising Total LiabilitiesAn uptick in total liabilities, even with a manageable debt-to-equity ratio, raises medium-term financial risk. Persistently higher liabilities can constrain cash available for capex or service expansion, increase interest or lease obligations, and reduce flexibility during operational stress.
Pressure To Sustain MarginsImproved margins to date are encouraging, but healthcare margins remain exposed to wage inflation, input cost rises, and reimbursement or pricing pressures. Sustainable margin expansion requires ongoing cost discipline and pricing power, which can be challenged by competitive or regulatory headwinds.
High Operational Intensity Of NICU/PICU ServicesDependence on high-acuity neonatal and pediatric intensive care raises structural cost intensity: specialized staff, expensive equipment and continuous bed utilization are required. This increases operating leverage and exposure to staffing shortages and cost inflation, pressuring margins if utilization dips.
Rainbow Childrens Medicare Limited News
RAINBOW FAQ
What was Rainbow Childrens Medicare Limited’s price range in the past 12 months?
Rainbow Childrens Medicare Limited lowest stock price was ₹1008.75 and its highest was ₹1644.10 in the past 12 months.
What is Rainbow Childrens Medicare Limited’s market cap?
Rainbow Childrens Medicare Limited’s market cap is ₹118.16B.
When is Rainbow Childrens Medicare Limited’s upcoming earnings report date?
Rainbow Childrens Medicare Limited’s upcoming earnings report date is May 25, 2026 which is in 57 days.
How were Rainbow Childrens Medicare Limited’s earnings last quarter?
Rainbow Childrens Medicare Limited released its earnings results on Jan 28, 2026. The company reported ₹7.1 earnings per share for the quarter, missing the consensus estimate of ₹7.15 by -₹0.05.
Is Rainbow Childrens Medicare Limited overvalued?
According to Wall Street analysts Rainbow Childrens Medicare Limited’s price is currently Overvalued.
Does Rainbow Childrens Medicare Limited pay dividends?
Rainbow Childrens Medicare Limited pays a Annually dividend of ₹3 which represents an annual dividend yield of 0.22%. See more information on Rainbow Childrens Medicare Limited dividends here
What is Rainbow Childrens Medicare Limited’s EPS estimate?
Rainbow Childrens Medicare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rainbow Childrens Medicare Limited have?
Rainbow Childrens Medicare Limited has 101,559,160 shares outstanding.
What happened to Rainbow Childrens Medicare Limited’s price movement after its last earnings report?
Rainbow Childrens Medicare Limited reported an EPS of ₹7.1 in its last earnings report, missing expectations of ₹7.15. Following the earnings report the stock price went up 0.177%.
Which hedge fund is a major shareholder of Rainbow Childrens Medicare Limited?
Currently, no hedge funds are holding shares in IN:RAINBOW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rainbow Childrens Medicare Limited
Rainbow Children's Medicare Limited operates a multi-specialty pediatric and obstetrics, and gynecology hospital chain in India. The company's child health services include general pediatrics, neonatalogy, surgery, gastroenterology and liver diseases, hematology and oncology, psychology, dentistry, pulmonology, endocrinology, nephrology, nutrition, psychiatry, ENT, cardiology, radiology, physiotherapy and rehabilitation, orthopedics, urology, ophthalmology, dermatology, allergy, neurosurgery, rheumatology, infectious disease, and cranio-maxillofacial surgery; intensive care unit, bone marrow transplant unit, anesthesia and pain management, kidney transplant, cochlear implant services; genetics and metabolic medicines; and laboratory, speech and language therapy, occupational therapy, pediatric and metabolic medicine, developmental and behavioral pediatrics, cerebral palsy care services. Its women health services include obstetrics and gynecology, painless delivery and labor, high risk pregnancy, pregnancy and delivery, childbirth preparation classes, vaginal birth after cesarean, breast feeding support, well women checkup, urogynecology, pre-pregnancy health checkup, minimally invasive surgery, breast care, fetal medicine, menopausal treatment, new-born care, women's nutrition, and diabetology. The company also provides fertility care services, such as fertility treatment, ovulation induction, intracytoplasmic sperm injection treatment, investigation, intrauterine insemination, intracytoplasmic morphologically selected sperm injection, assisted hatching, cryopreservation, sperm and oocyte donor treatments, frozen embryo transfer, surgical sperm retrieval, embryo donor treatments, reproductive surgery, pre-conception counselling, and andrology and urology. As of December 31, 2021, it operated 14 hospitals and 3 clinics in 6 cities with a total of 1,500 beds. The company was incorporated in 1998 and is based in Hyderabad, India.
Technical Analysis
HealthCare Global Enterprises Ltd.
―
Jubilant Pharmova Limited
―
Krsnaa Diagnostics Limited
―
RPG Life Sciences Limited
―
Vimta Labs Limited
―